PEPG: Koefisien rega marang pendapatan PepGen Corp
Diversified global supplies of biocomponents guarantee PepGen Inc. production stability. The market capitalization-to-revenue ratio reflects market sentiment dynamics, where characterizes this valuation parameter. The innovative EDO system ensures the efficient delivery of oligonucleotides into tissues. The development of unique treatments for rare pathologies paves the way for premium pricing and dominance in the neuromedicine segment.
Rincian metrik lan analitis perusahaan PepGen Inc. (PEPG)
- rega saham lan konsensus proyeksi valuasi:
- informasi kapitalisasi pasar:
- rincian nilai buku perusahaan:
- indikator beban kredit lan likuiditas emiten:
Koefisien Total Utang marang Modal PepGen Inc.|PEPG - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang ekuitas pepgen.com|PEPG - Gunggung utang perusahaan|Utang-utang marang nilai buku PepGen Corp|PEPG - Utang jangka dawa perusahaan|Kewajiban jangka cendhak PepGen|Likuiditas kritis pepgen.com
- indikator pendapatan resik lan kelipatan nilai:
PEPG - Bathi resik perusahaan|Prakiraan bathi resik PepGen Inc.|PEPG - Pangali P/E|Rasio prakiraan rega marang bathi pepgen.com|PEPG - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA PepGen Corp|PEPG - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajroning taun lumaku PepGen|PEPG - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan pepgen.com|PEPG - Wutah bathi saben saham ing taun lumaku|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep PepGen Inc.
- rincian pendapatan lan dodolan emiten:
Analisis umum perusahaan:PEPG - PepGen Inc
The P/S ratio measures the relationship between the market capitalization of PepGen Inc. (PEPG) and its annual sales volume, determining the cost of each dollar of revenue. For a biopharmaceutical business utilizing the EDO platform, this multiple reflects market expectations regarding the monetization of the RNA therapy patent perimeter. Analyzing the price-to-sales ratio allows for the identification of whether the asset is overbought or if its intellectual capital is undervalued. This price action reflects the balance between speculative demand and the actual scale of commercializing its developments.
Pesaing PepGen Inc.
BIIB (biogen.com) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S NBIX (Neurocrine Biosciences, Inc.)|Koefisien rega marang pendapatan Regencell Bioscience Ltd (RGC)|AXSM - Rasio rega marang pendapatan|ACAD (ACADIA Corp) - Rasio kapitalisasi marang pendapatan|XENE: Multiplikator P/S|Kapitalisasi marang pendapatan vikingtherapeutics.com|Kapitalisasi marang pendapatan SUPN|Catalyst Pharma (CPRX) - Koefisien rega marang pendapatan|Rasio rega marang pendapatan Denali Therapeutics Inc (DNLI)|HRMY: Rasio rega marang dodolan|Multiplikator P/S BHVN (Biohaven Ltd.)|amylyx.com (AMLX) - Rega marang dodolan|TRVI - Rasio rega marang pendapatan|Rasio rega marang dodolan PRAX|AVXL: Multiplikator P/S|Multiplikator rega marang pendapatan CeriBell EEG CBLL|Rasio rega marang pendapatan Prothena Biosciences|Rasio kapitalisasi marang pendapatan ALEC (Alector Therapeutics)|Multiplikator P/S ANNX|OMER - Rega marang dodolan|Neurogene Corp - Kapitalisasi marang pendapatan|Multiplikator P/S AC Immune Inc ACIU|VYGR - Rasio rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan NMRA (neumoratx.com)|Scilex (SCLX) - Rasio rega marang pendapatan|Rega marang dodolan Tevogen Bio Holdings Inc. (TVGN)|Rasio rega marang pendapatan Alpha Cognition Inc|Cognition Therapeutics Inc. - Rasio rega marang dodolan|Multiplikator P/S IKT|SAVA - Rega marang dodolan|Rasio rega marang pendapatan Assertio ASRT|COYA (Coya Therapeutics Inc) - Rasio rega marang dodolan|VistaGen Therapeutics Inc - Multiplikator P/S|Multiplikator rega marang pendapatan Ovid Therapeutics Inc. (OVID)|ABOS: Multiplikator P/S|Rega marang dodolan cervomed.com (CRVO)|Rasio rega marang pendapatan Alterity Therapeutics Ltd.|Rasio kapitalisasi marang pendapatan CLNN (Clene Nanomedicine)|Kapitalisasi marang pendapatan JUNS (Jupiter Neurosciences)|RLMD (Relmada Corp) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S ANVS (Annovis Bio, Inc.)|Koefisien rega marang pendapatan Grace Therapeutics Inc (GRCE)|AIFF - Rasio rega marang pendapatan|KLTO (Klotho Neurosciences Inc) - Rasio kapitalisasi marang pendapatan|NRSN: Multiplikator P/S|Kapitalisasi marang pendapatan Reviva Pharmaceuticals, Inc.|Kapitalisasi marang pendapatan MTVA|neuraxis.com (NRXS) - Koefisien rega marang pendapatan|Rasio rega marang pendapatan Helius Medical (HSDT)|PASG: Rasio rega marang dodolan|Multiplikator P/S NEUP (Neuphoria Therapeutics)|Minerva (NERV) - Rega marang dodolan|ATHA - Rasio rega marang pendapatan|Rasio rega marang dodolan ADXN|ALZN: Multiplikator P/S|Multiplikator rega marang pendapatan Cyclerion Therapeutics, Inc. CYCN|Rasio rega marang pendapatan Protagenic Therapeutics Inc.|Rasio kapitalisasi marang pendapatan KTTA (Pasithea)|Multiplikator P/S CRGT|ATXI - Rega marang dodolan|BrainStorm Cell Therapeutics - Kapitalisasi marang pendapatan|Multiplikator P/S Cara Therapeutics Inc. CARA|CHRO - Rasio rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan ELYM (Eliem Therapeutics)|intracellulartherapies.com (ITCI) - Rasio rega marang pendapatan|Rega marang dodolan longboardpharma.com (LBPH)|Rasio rega marang pendapatan Marinus Pharmaceuticals, Inc.|NKGen Biotech Inc - Rasio rega marang dodolan|Multiplikator P/S NRBO|SAGE - Rega marang dodolan|Rasio rega marang pendapatan Synaptogenix, Inc. SNPX|TRVN (trevena.com) - Rasio rega marang dodolan|Vigil Neuro - Multiplikator P/S|Multiplikator rega marang pendapatan anewmeds.com (WENA)|CERE: Multiplikator P/S
